15ml Semaglutide: Making Sense of This Concentration in UK Weight Management

How Wegovy's licensed pens are actually labelled in the UK

Wegovy pens are labelled by the mass of semaglutide they deliver, not by the total liquid volume inside. The licensed dose steps run from 0.25 mg through 0.5 mg, 1.0 mg and 1.7 mg up to a 2.4 mg maintenance dose, with a 7.2 mg high-dose pen approved by the MHRA in April 2026. Each pen contains the solution needed for one weekly injection; there is no measuring, no drawing up, no vial to calculate from. The NHS medicines information for semaglutide describes this pre-filled format precisely, and it is worth reading if you want to understand what an authentic pen looks and functions like before you encounter one.

The reason this matters is simple. A listing that describes semaglutide purely as a millilitre quantity ("15ml", for instance) is using the wrong unit for a licensed UK product. That mismatch is a practical red flag. It may indicate a product from outside the UK's regulated supply chain, a compound formulation produced without MHRA oversight, or simply a description that has been copied from a non-UK context. None of those situations represents a safe route to treatment. If you come across such a listing, spending sixty seconds on the GPhC register to check whether the seller holds a registered pharmacy premises is a habit worth building before you go any further.

The MHRA has been clear, and NHS patient information on semaglutide supports this: the medicine must come from a pharmacy you can verify. Volume-labelled listings represent a departure from how the licensed product is presented, and that departure is the decision point this page is designed to help you navigate.

Why "15ml semaglutide" appears, and what it usually refers to

The phrase circulates for a few distinct reasons, and the meaning differs depending on the context. In some countries, clinics dispense compounded semaglutide from multi-dose vials measured in millilitres; a 15ml vial at a typical concentration could correspond to several weeks of injections. This practice is not authorised in the UK. The MHRA licenses specific branded formulations, and you can read more about Wegovy and how its pens are regulated on this site; compounded semaglutide sits outside that framework regardless of the concentration used.

A second context is research supply, where semaglutide is produced for laboratory or academic purposes in measured volumes. This material is not manufactured for human administration and should never be used as a medicine.

A third, and more concerning, possibility is counterfeit product. The MHRA seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million in 2025 alone, including fake pens containing substances that were never semaglutide. A volume-described listing from an unverified seller is consistent with the kind of supply the agency has repeatedly warned the public about. You can report a suspect seller directly through the MHRA Yellow Card scheme, which covers both suspected side effects and suspected counterfeit or unlicensed products. That reporting route exists precisely because the agency relies on public intelligence to act quickly.

If you are trying to understand Wegovy's dosing schedule more broadly, our pages on semaglutide 1 mg and semaglutide 2 mg explain how the individual dose steps work and why treatment begins at the lowest level before progressing upward.

What the legitimate UK alternative looks like

In the UK, the lawful route to semaglutide for weight management runs through a licensed prescriber and a GPhC-registered pharmacy. A prescriber reviews your health history, current medicines, BMI and any weight-related conditions before deciding whether semaglutide is appropriate. If it is, a prescription is issued for a specific branded product at a specific starting dose, not for a volume of solution.

The dose your prescriber sets is adjusted over time based on how your body responds, following the schedule set out in the medicine's licensed information. That titration process is clinically managed; it is not something a fixed-volume vial from an unlicensed source can replicate safely. Our page on semaglutide 3 mg covers how higher dose steps fit into that managed progression, which is the same fundamental point approached from a different stage of treatment. For anyone curious about how volume descriptions like 5ml compare to what Wegovy's pen actually contains, that page covers the same fundamental point from a different starting question.

Cost is a reasonable part of the decision for most people, and it is worth knowing that legitimate private treatment through a regulated pharmacy includes the consultation, the prescription, and clinical oversight throughout, not just the medicine itself. The full picture of what private semaglutide treatment costs and what those costs cover is set out on the treatment options page, which is the clearest place to see what a regulated service includes before making a decision.

At nume, every consultation is read and assessed by a GPhC-registered Independent Prescriber (a real clinician, not automated software) on the same day it arrives. Wegovy is dispensed only from our GPhC-registered pharmacy (premises registration 9012878, verifiable at the GPhC register), through the licensed UK supply chain. Our clinical team, overseen by our lead prescriber, reviews each case individually.

The decision you are actually making here

Finding "15ml semaglutide" in a search result puts you at a decision point: is this a product I can trust, and is it the right medicine for me? The answer to the first question is almost always no, not because of the volume itself, but because licensed UK semaglutide does not come in that form. The answer to the second requires a proper clinical assessment, which is the only basis on which a prescriber can responsibly say yes.

Semaglutide is effective for weight management when it is the right treatment for the right person at the right dose, supported by lifestyle changes. NICE's appraisal of semaglutide for weight management (TA875) sets out the clinical evidence and the conditions under which it is recommended. The evidence is solid. The supply chain matters just as much as the evidence, though, because the best trial data in the world tells you nothing useful about a product that was not made to the same standard as the trial medicine.

If semaglutide sounds like it might be right for you, speaking with a prescriber is the natural next step. Check your eligibility by starting a free consultation with our clinical team.